NEWSA new strategic partnership with NerPharMa – Part of NMS Group

7 Maggio 2021

We are proud to announce our new strategic partnership with NerPharMa – Part of NMS Group, a veteran CDMO with a specialisation in oncology small molecule drug manufacture.

The aim of our alliance is to cooperate on commercial production of High Potent drugs and ADC-Payload.

Together we wil offer API development and formulated drug production services to third-party companies in increasingly crucial sectors of oncology and neurology.

This partnerhip is another step forward to the creation of our strategic hub of integrated services to support even more efficiently the Pharma needs.

Read more here 👇

https://www.pharmatechoutlook.com/news/nerpharma-and-icrom-sealed-partnership-agreement-pnid-75.html

https://manufacturingchemist.com/news/article_page/NerPharMa_and_ICROM_partner_on_highly_potent_drugs_and_ADC-payloads/176412

(In the pic  P. Morosini, CEO of Icrom srl, on the left, and A. Colombo, CEO of Nerpharma srl, on the right.)